Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Donohoue

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Trends in Biotechnology|August 6, 2017
Advances in Industrial Biotechnology Using CRISPR-Cas SystemsPaul D Donohoue, Rodolphe Barrangou, Andrew P May
Biochemistry|January 22, 2008
Identification of formyl kynurenine formamidase and kynurenine aminotransferase from Saccharomyces cerevisiae using crystallographic, bioinformatic and biochemical evidenceMark Wogulis, Erin R Chew, Paul D Donohoue, et al.
Archives of Biochemistry and Biophysics|August 12, 2009
Kinetic properties of ATP sulfurylase and APS kinase from Thiobacillus denitrificansSean C Gay, Jennifer L Fribourgh, Paul D Donohoue, et al.
Molecular Cell|November 7, 2014
Guide RNA functional modules direct Cas9 activity and orthogonalityAlexandra E Briner, Paul D Donohoue, Ahmed A Gomaa, et al.
Cell|October 28, 2022
Structural basis for Cas9 off-target activityMartin Pacesa, Chun-Han Lin, Antoine Cléry, et al.
Genome Biology|December 7, 2018
NmeCas9 is an intrinsically high-fidelity genome-editing platformNadia Amrani, Xin D Gao, Pengpeng Liu, et al.
Molecular Cell|September 3, 2021
Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cellsPaul D Donohoue, Martin Pacesa, Elaine Lau, et al.
Nature Methods|May 2, 2017
Mapping the genomic landscape of CRISPR-Cas9 cleavagePeter Cameron, Chris K Fuller, Paul D Donohoue, et al.
Cytotherapy|April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitnessElaine Lau, George Kwong, Tristan W Fowler, et al.
Nature Biotechnology|November 20, 2019
Harnessing type I CRISPR-Cas systems for genome engineering in human cellsPeter Cameron, Mary M Coons, Sanne E Klompe, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Trends in Biotechnology|August 6, 2017
Advances in Industrial Biotechnology Using CRISPR-Cas SystemsPaul D Donohoue, Rodolphe Barrangou, Andrew P May
Biochemistry|January 22, 2008
Identification of formyl kynurenine formamidase and kynurenine aminotransferase from Saccharomyces cerevisiae using crystallographic, bioinformatic and biochemical evidenceMark Wogulis, Erin R Chew, Paul D Donohoue, et al.
Archives of Biochemistry and Biophysics|August 12, 2009
Kinetic properties of ATP sulfurylase and APS kinase from Thiobacillus denitrificansSean C Gay, Jennifer L Fribourgh, Paul D Donohoue, et al.
Molecular Cell|November 7, 2014
Guide RNA functional modules direct Cas9 activity and orthogonalityAlexandra E Briner, Paul D Donohoue, Ahmed A Gomaa, et al.
Cell|October 28, 2022
Structural basis for Cas9 off-target activityMartin Pacesa, Chun-Han Lin, Antoine Cléry, et al.
Genome Biology|December 7, 2018
NmeCas9 is an intrinsically high-fidelity genome-editing platformNadia Amrani, Xin D Gao, Pengpeng Liu, et al.
Molecular Cell|September 3, 2021
Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cellsPaul D Donohoue, Martin Pacesa, Elaine Lau, et al.
Nature Methods|May 2, 2017
Mapping the genomic landscape of CRISPR-Cas9 cleavagePeter Cameron, Chris K Fuller, Paul D Donohoue, et al.
Cytotherapy|April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitnessElaine Lau, George Kwong, Tristan W Fowler, et al.
Nature Biotechnology|November 20, 2019
Harnessing type I CRISPR-Cas systems for genome engineering in human cellsPeter Cameron, Mary M Coons, Sanne E Klompe, et al.
Pageof 2